4//SEC Filing
WILSON GAYLE E 4
Accession 0001127602-18-005574
CIK 0000882095other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:24 PM ET
Size
8.1 KB
Accession
0001127602-18-005574
Insider Transaction Report
Form 4
WILSON GAYLE E
Director
Transactions
- Exercise/Conversion
Common Stock
2018-02-09$26.61/sh+60,000$1,596,900→ 182,258 total - Sale
Common Stock
2018-02-09$77.92/sh−60,000$4,675,080→ 122,258 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2018-02-09−60,000→ 0 totalExercise: $26.61Exp: 2018-05-08→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Sale prices reported for the transactions reported here range from $77.88 to $78.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F2]Options vest 100% on the first anniversary date of the grant.
Documents
Issuer
GILEAD SCIENCES INC
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001198227
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:24 PM ET
- Size
- 8.1 KB